These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 37716668

  • 21. Molecular evidence supports the expansion of visceral leishmaniasis towards non-program districts of Nepal.
    Shrestha M, Khatri-Chhetri M, Poudel RC, Maharjan J, Dumre SP, Manandhar KD, Pandey BD, Pun SB, Pandey K.
    BMC Infect Dis; 2019 May 21; 19(1):444. PubMed ID: 31113385
    [Abstract] [Full Text] [Related]

  • 22. Investigation of Visceral LeishmaniasisTransmission in Selected Districts of Nepal.
    Basnyat S, Banjara MR, Ghimire P, Matlashewski G, Singh A.
    J Nepal Health Res Counc; 2022 Jun 02; 20(1):194-201. PubMed ID: 35945875
    [Abstract] [Full Text] [Related]

  • 23. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.
    Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, Siddhivinayak H, Kroeger A, Boelaert M.
    PLoS Negl Trop Dis; 2009 Jun 02; 3(1):e355. PubMed ID: 19159009
    [Abstract] [Full Text] [Related]

  • 24. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI, Hossain F, Ghosh P, Chowdhury R, Hossain MS, Jewell C, Cruz I, Picado A, Mondal D, Adams ER.
    Parasit Vectors; 2021 Feb 17; 14(1):111. PubMed ID: 33597000
    [Abstract] [Full Text] [Related]

  • 25. Knowledge, attitude and practices towards visceral leishmaniasis among HIV patients: A cross-sectional study from Bihar, India.
    J S D, Gupta AK, Veeri RB, Garapati P, Kumar R, Dhingra S, Murti K, Ravichandiran V, Pandey K.
    PLoS One; 2021 Feb 17; 16(8):e0256239. PubMed ID: 34404087
    [Abstract] [Full Text] [Related]

  • 26. Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India.
    Cameron MM, Acosta-Serrano A, Bern C, Boelaert M, den Boer M, Burza S, Chapman LA, Chaskopoulou A, Coleman M, Courtenay O, Croft S, Das P, Dilger E, Foster G, Garlapati R, Haines L, Harris A, Hemingway J, Hollingsworth TD, Jervis S, Medley G, Miles M, Paine M, Picado A, Poché R, Ready P, Rogers M, Rowland M, Sundar S, de Vlas SJ, Weetman D.
    Parasit Vectors; 2016 Jan 27; 9():25. PubMed ID: 26812963
    [Abstract] [Full Text] [Related]

  • 27. Epidemiology of visceral leishmaniasis in Shebelle Zone of Somali Region, eastern Ethiopia.
    Alebie G, Worku A, Yohannes S, Urga B, Hailu A, Tadesse D.
    Parasit Vectors; 2019 May 06; 12(1):209. PubMed ID: 31060585
    [Abstract] [Full Text] [Related]

  • 28. Survey of domestic cattle for anti-Leishmania antibodies and Leishmania DNA in a visceral leishmaniasis endemic area of Bangladesh.
    Alam MS, Ghosh D, Khan MG, Islam MF, Mondal D, Itoh M, Islam MN, Haque R.
    BMC Vet Res; 2011 Jun 08; 7():27. PubMed ID: 21651757
    [Abstract] [Full Text] [Related]

  • 29. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
    Chapman LAC, Spencer SEF, Pollington TM, Jewell CP, Mondal D, Alvar J, Hollingsworth TD, Cameron MM, Bern C, Medley GF.
    Proc Natl Acad Sci U S A; 2020 Oct 13; 117(41):25742-25750. PubMed ID: 32973088
    [Abstract] [Full Text] [Related]

  • 30. [Monitoring of canine leishmaniasis in northern Italy: an update from a scientific network].
    Capelli G, Baldelli R, Ferroglio E, Genchi C, Gradoni L, Gramiccia M, Maroli M, Mortarino M, Pietrobelli M, Rossi L, Ruggiero M.
    Parassitologia; 2004 Jun 13; 46(1-2):193-7. PubMed ID: 15305715
    [Abstract] [Full Text] [Related]

  • 31. The ongoing risk of Leishmania donovani transmission in eastern Nepal: an entomological investigation during the elimination era.
    Roy L, Cloots K, Uranw S, Rai K, Bhattarai NR, Smekens T, Hendrickx R, Caljon G, Hasker E, Das ML, Van Bortel W.
    Parasit Vectors; 2023 Nov 06; 16(1):404. PubMed ID: 37932813
    [Abstract] [Full Text] [Related]

  • 32. Seropositivity of Visceral leishmaniasis on people of VL endemic three districts of Nepal.
    Basnyat S, Banjara MR, Ghimire P, Matlashewski G, Singh A.
    Parasitol Int; 2021 Feb 06; 80():102236. PubMed ID: 33147500
    [Abstract] [Full Text] [Related]

  • 33. Relationship between sand fly fauna and kala-azar endemicity in Bangladesh.
    Alam MS, Wagatsuma Y, Mondal D, Khanum H, Haque R.
    Acta Trop; 2009 Oct 06; 112(1):23-5. PubMed ID: 19501561
    [Abstract] [Full Text] [Related]

  • 34. Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models.
    Le Rutte EA, Coffeng LE, Bontje DM, Hasker EC, Postigo JA, Argaw D, Boelaert MC, De Vlas SJ.
    Parasit Vectors; 2016 Jan 19; 9():24. PubMed ID: 26787302
    [Abstract] [Full Text] [Related]

  • 35. Indoor residual spraying for kala-azar vector control in Bangladesh: A continuing challenge.
    Chowdhury R, Chowdhury V, Faria S, Islam S, Maheswary NP, Akhter S, Islam MS, Dash AP, Kroeger A, Banu Q.
    PLoS Negl Trop Dis; 2018 Oct 19; 12(10):e0006846. PubMed ID: 30273402
    [Abstract] [Full Text] [Related]

  • 36. Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL management and control services in Bangladesh.
    Maruf S, Sagar SK, Rashid MU, Uddin MR, Ghosh D, Ghosh P, Nath R, Sohel ANM, Aktaruzzaman MM, Islam MN, Banjara MR, Kroeger A, Aseffa A, Mondal D.
    J Infect Public Health; 2023 Nov 19; 16(11):1716-1721. PubMed ID: 37741011
    [Abstract] [Full Text] [Related]

  • 37. Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities.
    Joshi AB, Banjara MR, Pokhrel S, Jimba M, Singhasivanon P, Ashford RW.
    Kathmandu Univ Med J (KUMJ); 2006 Nov 19; 4(4):488-96. PubMed ID: 18603960
    [Abstract] [Full Text] [Related]

  • 38. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.
    Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, Thomas T, Haque R.
    PLoS Negl Trop Dis; 2010 Oct 05; 4(10):. PubMed ID: 20957193
    [Abstract] [Full Text] [Related]

  • 39. Molecular and Serological Evidence of Leishmania Infection in Stray Dogs from Visceral Leishmaniasis-Endemic Areas of Bangladesh.
    Akter S, Alam MZ, Nakao R, Yasin G, Kato H, Katakura K.
    Am J Trop Med Hyg; 2016 Oct 05; 95(4):795-799. PubMed ID: 27382083
    [Abstract] [Full Text] [Related]

  • 40. Integrating Case Detection of Visceral Leishmaniasis and Other Febrile Illness with Vector Control in the Post-Elimination Phase in Nepal.
    Banjara MR, Das ML, Gurung CK, Singh VK, Joshi AB, Matlashewski G, Kroeger A, Olliaro P.
    Am J Trop Med Hyg; 2019 Jan 05; 100(1):108-114. PubMed ID: 30426921
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.